Sipuleucel-T
Sipuleucel-T is an autologous cellular immunotherapy designed to induce an immune response against prostate cancer by targeting prostate acid phosphatase (PAP) . It is applied in clinical and preclinical research for studying antigen-specific T-cell activation and efficacy in both in vitro assays and in vivo models.
Product Specifications
CAS Number
917381-47-6
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog